Daily news email for August 27, 2010 | Click here for updated news
SourceSolution News
New reporting features added to the Supplier Relationship Management system. Sign up here for our daily webinar to learn more.
Search over 86,000 clinical trials by phase of development and indication at www.sourcesolution.com
PlanIt client portal software lets you exchange and track documents, manage budgets and assign tasks. 3 day implementation!
|
BioSpace
EU Drugs Regulator Reviews Safety of GlaxoSmithKline's Flu Jab, Probes Swine Flu Shot, Narcolepsy Link
Eli Lilly and Company Wins Longer Halt Of Generic Strattera Sales
Celgene Announces Appointment of as Senior Vice President and Chief Financial Officer; Could Be Sign of s Intention to Go International
Yale University Team Finds a Genetic Rarity: A Mutation that Restores Health
Genentech, ImmunoGen, Inc. Receives Refuse to File Letter from FDA for Drug T-DM1, Stock Drops 38.02% at 11:08AM EDT
|
BioSpace - Breaking News
Landauer Declares Regular Cash Dividend
Charles River Laboratories (Massachusetts) Implements $300 Million Accelerated Stock Repurchase Program
Lotus Pharmaceuticals, Inc. Starts China Clinical Trial of Asthma Drug
First European Patent Claims Now Allowed for Microwave Peptide Synthesis, CEM Corporation Study
Hospira, Inc. to Present at Morgan Stanley Global Healthcare Conference Sept. 13
|
Pharma News - Business Wire
Company Profile for Quintiles
Maven Semantic: Nanotechnology Research Database
Company Profile for The Channel Group, LLC
Independent Drugstore Lobby to Congress: No Transparency For Us, More for PBMs
Biomagnetics Announces LOI to Acquire Hubei Tianyuan Chemical CompanyThird Chinese Asset Targeted at $1.50 BMGP Share Price
|
Pharma News - PharmiWeb
Epigenetics Therapeutics to 2017 High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma
Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Dorothee Foernzler at Roche to speak at Cancer Conference Oct 20-22 California
NICE proposes to restrict access to Velcade® (bortezomib) in newly diagnosed multiple myeloma patients
Key Bio Nano Consulting partner develops novel nanolitre scale technique for determining protein stability and ligand-binding affinity
|
Pharma News - PR Newswire
Fosun Pharma Acquires $14 Million of Chindex Stock
Americans to U.S. Food and Drug Administration: Preserve Life-Saving Medicines; Reduce Antibiotic Use in Food Animal Production
UPDATE: China PharmaHub Corp. Introduces a 'Magic Bullet' Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
Vanda Pharmaceuticals Initiates Phase III Clinical Study Aimed at Resetting the Body Clock
China PharmaHub Corp. Introduces a 'Magic Bullet' Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
|
